After subtracting rebates and discounts, net drug prices paid by health plans fell 2.6 percent, compared to a 3.7 percent decline in the first quarter of 2019, according to an analysis from SSR Health, a data and analytics firm that focuses on drug prices.
Discounts on wholesale drug prices reached 50.4 percent in the first quarter, the highest level in a decade, according to STAT.
Drugmakers and pharmacy benefit managers have faced increased scrutiny from lawmakers on their pricing practices in the last five years, contributing to the slowing rate of price hikes, STAT reported.
Drug price hikes began to slow in 2018 when the president began criticizing drugmakers about their costs and Congress began exploring legislation to lower costs, STAT reported.
But net prices are likely to stop falling and may rise slightly this year, depending on the inflation rate, according to STAT.
Read the full article here.
More articles on pharmacy:
Pharmacist salaries across the most common work settings
WHO continues hydroxychloroquine trials after evaluating safety
FDA asks 5 drugmakers to recall metformin products
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
